Aortic Valve Surgery
10
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Metabolic Profile and Tissue Perfusion in Patients Undergoing Open Heart Surgery With Minimal Invasive Versus Conventional Extracorporeal Circulation
Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR
Safety and Performance Evaluation of CPB Venous and Arterial Cannulas
Methylene Blue-Enhanced Ultrafiltration Improves Outcomes After Cardiopulmonary Bypass
Post-market Safety and Performance Outcomes of the VIVERE® Bovine Pericardial Bioprosthetic Valve
Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry
10 Versus 20 Minutes Treatment of Human Pericardium With Glutaraldehyde in OZAKI Procedure
Use of the SonoSite Probe for Measuring Jugular Venous Pressure
Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery
Early Surgery for Patients With Asymptomatic Aortic Stenosis